What's Going On With Candel Therapeutics Stock?
What's Going On With Candel Therapeutics Stock?
Candel Therapeutics, Inc. (NASDAQ:CADL) shares are trading higher Thursday after the company received FDA orphan drug designation for CAN-2409 for the treatment of pancreatic cancer.
Candel Therapeutics, Inc.（納斯達克股票代碼：CADL）週四股價走高，此前該公司獲得了美國食品藥品管理局用於治療胰腺癌的 CAN-2409 孤兒藥稱號。
The Details:
細節：
"We recently reported data from the phase 2 randomized clinical trial of CAN-2409 in borderline resectable pancreatic cancer, showing that CAN-2409, when added to standard of care, more than doubled the median overall survival obtained with standard of care alone," said Paul Peter Tak, MD, PhD, CEO of Candel.
Candel 首席執行官 Paul Peter Tak 醫學博士、博士表示：“我們最近報告了針對臨界可切除胰腺癌的 CAN-2409 二期隨機臨床試驗的數據，顯示 CAN-2409 加到標準護理中，是僅使用標準護理獲得的中位總存活率的兩倍多。”
"We are pleased that the FDA has now granted Candel with both Orphan Drug and Fast Track Designation to this program, as we seek to reshape the treatment paradigm in pancreatic cancer."
“我們很高興美國食品藥品管理局現已授予Candel該計劃的孤兒藥和快速通道稱號，因爲我們正在尋求重塑胰腺癌的治療模式。”
Candel shares are moving on heavy trading volume following the company's announcement. According to data from Benzinga Pro, more than 20.7 million shares have been traded in the session, compared to the stock's 100-day average of just over 4 million shares.
該公司宣佈後，Candel的股票交易量居高不下。根據Benzinga Pro的數據，該交易日交易了超過2,070萬股股票，而該股的100天平均交易量略高於400萬股。
Related News: What's Going On With Chinese EV Stocks Nio And XPeng?
相關新聞： 中國電動汽車股票蔚來和小鵬怎麼了？
Is CADL A Good Stock To Buy?
CADL 是一隻值得買入的好股票嗎？
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages – like Candel Therapeutics's page for example – there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
投資者在決定股票是否值得買入時可以做出一些決定。除了可以在Benzinga的報價頁面（例如Candel Therapeutics的頁面）上找到的估值指標和價格走勢外，還有一些因素，例如公司是否每季度支付股息或購買大部分股票。
These are known as capital allocation programs. Candel Therapeutics does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga's dividend calendar for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
這些被稱爲資本分配計劃。Candel Therapeutics不支付股息，但顯然有幾種方法可以向股東返還價值。您可以隨時在Benzinga的股息日曆中搜索下一家即將派發股息的公司，並確定持有該公司股份可以獲得什麼樣的收益率。
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on Candel Therapeutics will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
回購計劃顯然是不同的，而且變化很大。公司可以批准回購計劃，並在回購獲得批准的時間內酌情購買股票。瀏覽Candel Therapeutics的最新消息通常可以得出該公司最近是否批准了回購計劃。回購計劃通常作爲股價的支撐，作爲需求的支撐。
CADL Price Action: According to Benzinga Pro, Candel Therapeutics shares are up 25.1% at $6.38 at the time of publication Thursday.
CADL價格走勢：根據Benzinga Pro的數據，Candel Therapeutics的股價在週四發佈時上漲了25.1％，至6.38美元。
Image: Myriams-Fotos from Pixabay
圖片：來自 Pixabay 的 Myriams-Fotos
譯文內容由第三人軟體翻譯。